mianserin has been researched along with Hyperlipidemias in 1 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Hyperlipidemias: Conditions with excess LIPIDS in the blood.
Excerpt | Relevance | Reference |
---|---|---|
"5% in mean body weight over the course of the study in the mirtazapine group that appeared to reach a plateau at 3 weeks, while no increase was observed in the placebo group." | 5.10 | The effects of mirtazapine on plasma lipid profiles in healthy subjects. ( Ekstrom, RD; Esposito, SM; Ford, AL; Golden, RN; Nicholas, LM, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nicholas, LM | 1 |
Ford, AL | 1 |
Esposito, SM | 1 |
Ekstrom, RD | 1 |
Golden, RN | 1 |
1 trial available for mianserin and Hyperlipidemias
Article | Year |
---|---|
The effects of mirtazapine on plasma lipid profiles in healthy subjects.
Topics: Adult; Antidepressive Agents, Tricyclic; Body Weight; Cholesterol; Coronary Disease; Dose-Response R | 2003 |